Category:
Active Pharmaceutical Ingredients
CAS NO:
700874-72-2
Standard:
In-house Standards,
Oncology Melanoma
Galunisertib (LY 2157299) is a potent, oral TGF-beta receptor I inhibitor developed for oncology. Its molecular formula is C24H28N6O4 with CAS number 1203868-23-0. Synthesis involves complex heterocyclic coupling to ensure high purity for clinical trials.
Strictly for research use only; not approved for human therapy. Store at -20°C under inert atmosphere. Handle with PPE due to potential cytotoxicity and mutagenic risks associated with small molecule inhibitors.